Clinical Trial Update: Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pimavanserin for depression in adults with Parkinson's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pimavanserin (pimavanserin)

Snippet

Sponsor: ACADIA Pharmaceuticals Inc. | Conditions: Treatment of Depression in Adults With Parkinson's Disease (PD) | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31